deltatrials
Recruiting PHASE3 INTERVENTIONAL 3-arm NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease (AMAY)

A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn's Disease

Sponsor: Eli Lilly and Company

Conditions Crohn's Disease
Interventions Mirikizumab
Updated 34 times since 2022 Last updated: Mar 2, 2026 Started: Mar 13, 2024 Primary completion: Dec 31, 2027 Completion: Apr 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Crohn's Disease, this trial is actively recruiting participants. The trial is conducted by Eli Lilly and Company and has accumulated 34 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Apr 2024 · 5 months · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Jan 2025 · 2 months · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Apr 2025 · 59 days · monthly snapshot~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Aug 2025 · 31 days · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – ~Nov 2025 · 31 days · monthly snapshot~Nov 2025 – ~Jan 2026 · 2 months · monthly snapshot~Jan 2026 – ~Mar 2026 · 59 days · monthly snapshot~Mar 2026 – present · 5 months · monthly snapshot

Change History

34 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE3

  2. Jan 2026 — Mar 2026 [monthly]

    Recruiting PHASE3

  3. Nov 2025 — Jan 2026 [monthly]

    Recruiting PHASE3

  4. Oct 2025 — Nov 2025 [monthly]

    Recruiting PHASE3

  5. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE3

▶ Show 29 earlier versions

  1. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE3

  2. Jul 2025 — Aug 2025 [monthly]

    Recruiting PHASE3

  3. Jun 2025 — Jul 2025 [monthly]

    Recruiting PHASE3

  4. May 2025 — Jun 2025 [monthly]

    Recruiting PHASE3

  5. Apr 2025 — May 2025 [monthly]

    Recruiting PHASE3

  6. Feb 2025 — Apr 2025 [monthly]

    Recruiting PHASE3

  7. Jan 2025 — Feb 2025 [monthly]

    Recruiting PHASE3

  8. Nov 2024 — Jan 2025 [monthly]

    Recruiting PHASE3

  9. Oct 2024 — Nov 2024 [monthly]

    Recruiting PHASE3

  10. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE3

  11. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  12. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE3

  13. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  14. May 2024 — Jun 2024 [monthly]

    Recruiting PHASE3

  15. Apr 2024 — May 2024 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  16. Nov 2023 — Apr 2024 [monthly]

    Not Yet Recruiting PHASE3

  17. Oct 2023 — Nov 2023 [monthly]

    Not Yet Recruiting PHASE3

  18. Sep 2023 — Oct 2023 [monthly]

    Not Yet Recruiting PHASE3

  19. Aug 2023 — Sep 2023 [monthly]

    Not Yet Recruiting PHASE3

  20. Jul 2023 — Aug 2023 [monthly]

    Not Yet Recruiting PHASE3

  21. Jun 2023 — Jul 2023 [monthly]

    Not Yet Recruiting PHASE3

  22. May 2023 — Jun 2023 [monthly]

    Not Yet Recruiting PHASE3

  23. Apr 2023 — May 2023 [monthly]

    Not Yet Recruiting PHASE3

  24. Mar 2023 — Apr 2023 [monthly]

    Not Yet Recruiting PHASE3

  25. Feb 2023 — Mar 2023 [monthly]

    Not Yet Recruiting PHASE3

  26. Jan 2023 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE3

  27. Dec 2022 — Jan 2023 [monthly]

    Not Yet Recruiting PHASE3

  28. Nov 2022 — Dec 2022 [monthly]

    Not Yet Recruiting PHASE3

  29. Sep 2022 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alessandria, Italy , Atlanta, United States , Beersheba, Israel , Bergamo, Italy , Bologna, Italy , Boston, United States , Braga, Portugal , Brussels, Belgium , Bunkyō City, Japan , Burlington, United States and 61 more locations